SRNE Sorrento Therapeutics, Inc.

$0.00

Sorrento Therapeutics, Inc. (SRNE) is expected to report earnings on August 25, 2026, after the market close.

Earnings Date
Aug 25
Tuesday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sorrento Therapeutics, Inc.

Sorrento Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, acquisition, development and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the United States.

Sector

Healthcare